Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma: NRG Oncology/GOG Study 279 is a research paper published in Journal of Clinical Oncology (2024). On theSindex it has a DataRank of 0.637. It has been cited 19 times, with 19 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.449
From this paper's citation signal
Citation Network Contribution
0.188
From 9 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 19 citers.
NCI NIH HHS
Grant: UG1 CA233330
NCI NIH HHS
Grant: P30 CA013148
NCI NIH HHS
Grant: P30 CA142543
NCI NIH HHS
Grant: U10 CA180822
NCI NIH HHS
Grant: U10 CA180868
NCATS NIH HHS
Grant: UL1 TR001412
FWCI
8.55
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals